Amivantamab + Hyaluronidase (Human Recombinant)

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Amivantamab amivantamab
Hyaluronidase (Human Recombinant) hyaluronidase-human-recombinant

Brands with this exact combination

Brand	Composition & strength	Manufacturer
Rybrevant FasproMX US	injection Amivantamab 1,600 mg/10 mL + Hyaluronidase (Human Recombinant) 20,000 mg/10 mL injection Amivantamab 2,240 mg/14 mL + Hyaluronidase (Human Recombinant) 28,000 mg/14 mL injection Amivantamab 2,400 mg/15 mL + Hyaluronidase (Human Recombinant) 30,000 mg/15 mL injection Amivantamab 3,520 mg/22 mL + Hyaluronidase (Human Recombinant) 44,000 mg/22 mL Other 1 compositions	Janssen Biotech, Inc.
AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT)US	3,520 mg/22 mL / 44,000 mg/22 mL / 1,600 mg/10 mL / 20,000 mg/10 mL / 2,240 mg/14 mL / 28,000 mg/14 mL	Janssen Biotech, Inc.

Brand

Composition & strength

Manufacturer

Rybrevant FasproMX US

injection Amivantamab 1,600 mg/10 mL + Hyaluronidase (Human Recombinant) 20,000 mg/10 mL
injection Amivantamab 2,240 mg/14 mL + Hyaluronidase (Human Recombinant) 28,000 mg/14 mL
injection Amivantamab 2,400 mg/15 mL + Hyaluronidase (Human Recombinant) 30,000 mg/15 mL
injection Amivantamab 3,520 mg/22 mL + Hyaluronidase (Human Recombinant) 44,000 mg/22 mL

Other 1 compositions

Janssen Biotech, Inc.

AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT)US

3,520 mg/22 mL / 44,000 mg/22 mL / 1,600 mg/10 mL / 20,000 mg/10 mL / 2,240 mg/14 mL / 28,000 mg/14 mL

Janssen Biotech, Inc.

Same combination in other markets

No product with this combination is recorded in the other covered markets yet.

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.